Loading…
Lactose (India) (BSE 524202)₹104.45−0.52%Pharmaceuticals
Lactose (India) is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 21.9 against a peer median of 14.5, and ROCE of 11.1% against a peer median of 14.0%, and latest-quarter sales growth of 64.9% against a peer median of 14.1%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Laboratories | 142 | 9.5 | 17.9 | 16.8 | 0.08 | 0.0 | 112 | 15 | −30.3 | 48.2 | vs BSE 524202 |
| Panchsheel Organics | 141 | 13.0 | 10.0 | 7.9 | 0.04 | 3.0 | 107 | 11 | 9.5 | −46.5 | vs BSE 524202 |
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs BSE 524202 |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs BSE 524202 |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 524202 |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs BSE 524202 |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | — |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BSE 524202 |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs BSE 524202 |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs BSE 524202 |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 524202 |
| Peer median | 132 | 14.5 | 14.0 | 13.4 | 0.18 | 0.0 | 112 | 11 | 14.1 | 44.9 |
Listed companies closest to Lactose (India) in Pharmaceuticals include Quest Laboratories, Panchsheel Organics, Par Drugs and Chemicals, Speciality Medicines, Parnax Lab, Bal Pharma, Krebs Biochemicals and Industries, Asston Pharmaceuticals.
Quest Laboratories, with a market cap of ₹142 Cr.
Lactose (India) trades at a P/E of 21.9; the median of its peer set is 14.5. A P/E above or below the median is a description, not a judgement on value.
Lactose (India)'s return on capital employed is 11.1%, below the peer median of 14.0%.